The victim count from last year's data breach has increased significantly. The number of victims impacted by the Change ...

Q4 2024 Earnings Call Transcript January 30, 2025 Cigna Corporation misses on earnings expectations. Reported EPS is $6.64 ...

The villains were injectable specialty drugs like Keytruda and inpatient surgical procedures for seriously ill patients.

Cigna Group inc. (NYSE: CI) shares are rebounding Friday after dropping on Thursday following a fourth-quarter earnings miss.

Cantor Fitzgerald lowered the firm’s price target on Cigna (CI) to $350 from $400 and keeps an Overweight rating on the shares. Cantor is ...

Oppenheimer lowered the firm’s price target on Cigna (CI) to $375 from $400 and keeps an Outperform rating on the shares. The firm notes ...

Shares of Cigna ( CI -8.00%) were dropping Thursday. The stock was down 8.4% as of 1:20 p.m. ET but had lost as much as 11.3% ...

Cigna blamed lower-than-expected fourth-quarter returns on its stop-loss insurance business that insures employers from ...

Cigna Group closed 23.69% below its 52-week high of $370.83, which the company reached on September 16th.

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Bloomfield-based Cigna announced this week a new initiative that aims to reduce out-of-pocket prescription-drug costs and make those costs more transparent.

Health insurance company Cigna (NYSE:CI) announced in Q4 CY2024, with sales up 28.4% year on year to $65.65 billion. The ...